We help our clients to accelerate their drug discovery projects by providing crucial insights into the three-dimensional structure of their drug targets. We can also help you plan a strategy for your structure-based drug design project, with fragment library screening and structure-based lead optimization.
By serving large pharma and biotech companies worldwide for more than 15 years, the SARomics Biostructures team has established a proven track record of success and has gathered extensive experience in all aspects of structural biology and structure-based drug design. Each year on average, we work with over 100 structural biology and early-stage drug discovery projects. Since 2006 more than 500 disclosable protein structures have been submitted to the PDB, and our staff, have contributed to more than 240 structural papers published in leading journals
like Nature, Nature Commun., Eur. J. Med. Chem., J. Biol. Chem, J. Synchrotron Rad., Sci. Rep., PNAS, J. Med. Chem., FASEB J., JACS, Biochemistry, etc.
Thanks to the high professional level and broad experience, the services provided by our employees are genuinely among the most competitive on the market. Use the form below to contact us!